CH584755A5 - - Google Patents
Info
- Publication number
- CH584755A5 CH584755A5 CH872872A CH872872A CH584755A5 CH 584755 A5 CH584755 A5 CH 584755A5 CH 872872 A CH872872 A CH 872872A CH 872872 A CH872872 A CH 872872A CH 584755 A5 CH584755 A5 CH 584755A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2765371A GB1395907A (en) | 1971-06-12 | 1971-06-12 | Antibiotics |
Publications (1)
Publication Number | Publication Date |
---|---|
CH584755A5 true CH584755A5 (xx) | 1977-02-15 |
Family
ID=10263082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH872872A CH584755A5 (xx) | 1971-06-12 | 1972-06-12 |
Country Status (6)
Country | Link |
---|---|
US (1) | US4289703A (xx) |
JP (2) | JPS548753B1 (xx) |
BE (1) | BE893376Q (xx) |
CH (1) | CH584755A5 (xx) |
DE (1) | DE2227739C2 (xx) |
GB (1) | GB1395907A (xx) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1565083A (en) * | 1976-02-20 | 1980-04-16 | Beecham Group Ltd | Pseudomonic acid amides |
GB1587058A (en) * | 1976-06-15 | 1981-03-25 | Beecham Group Ltd | Oxiranylmethyltetrahydropyran derivatives |
GB1577730A (en) * | 1976-10-23 | 1980-10-29 | Beecham Group Ltd | Treatment of infections with pseudomonicacid salts or esters thereof |
US4206224A (en) * | 1976-10-23 | 1980-06-03 | Beecham Group Limited | Treatment of infections |
CA1103264A (en) * | 1977-09-30 | 1981-06-16 | Norman H. Rogers | Purification of pseudomonic acid |
EP0003069B1 (en) * | 1977-11-01 | 1981-05-20 | Beecham Group Plc | Pseudomonic acid c, pharmaceutically acceptable salts or esters thereof, processes for their preparation and pharmaceutical or veterinary compositions containing them |
GB2009154B (en) * | 1977-11-10 | 1982-06-23 | Beecham Group Ltd | Antibacterial compounds |
IL56003A0 (en) * | 1977-12-03 | 1979-01-31 | Beecham Group Ltd | Novel thiol esters of monic acid, their preparation and pharmaceutical compositions containing them |
EP0004412A1 (en) * | 1978-01-21 | 1979-10-03 | GKN Transmissions Limited | Continuously variable transmission mechanisms |
CA1115699A (en) * | 1978-05-20 | 1982-01-05 | Alan D. Curzons | Lithium pseudomonate and its preparation |
DE3066424D1 (en) * | 1979-11-10 | 1984-03-08 | Beecham Group Plc | Antibacterial derivatives of monic acid, processes for their preparation and compositions containing them |
EP0042233A1 (en) * | 1980-06-14 | 1981-12-23 | Beecham Group Plc | 13-oxo-monic acid and its salts and esters, process for their production, and compositions containing them |
US4436751A (en) | 1980-12-31 | 1984-03-13 | Beecham Group Limited | Nitrobenzyl monates antibacterial compounds |
CA1196284A (en) * | 1982-05-28 | 1985-11-05 | Joshua Oduro-Yeboah | Pharmaceutical formulations |
GB8313035D0 (en) * | 1983-05-12 | 1983-06-15 | Beecham Group Plc | Compound |
GB8415579D0 (en) * | 1984-06-19 | 1984-07-25 | Beecham Group Plc | Compounds |
GB8530796D0 (en) * | 1985-12-13 | 1986-01-22 | Beecham Group Plc | Pharmaceutical composition |
US5594026A (en) * | 1990-12-11 | 1997-01-14 | Smithkline Beecham Group P.L.C. | Polymorphs of crystalline mupirocin |
GB9026873D0 (en) * | 1990-12-11 | 1991-01-30 | Beecham Group Plc | Novel compounds |
CN1203184C (zh) | 1999-02-03 | 2005-05-25 | 拜奥盖尔药厂有限公司 | 经微生物学方法制备假单胞菌酸a抗生素的方法 |
HUP0105286A3 (en) | 1999-02-03 | 2003-03-28 | Biogal Gyogyszergyar | Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth |
ES2228294T1 (es) * | 2001-06-21 | 2005-04-16 | Biogal Gyogyszergyar Rt. | Proceso de fermentacion metabolico controlado para la produccion de acido pseudomonico. |
DE20220885U1 (de) * | 2001-12-28 | 2004-06-24 | BIOGAL Gyógyszergyár Rt. | Kristallines und amorphes Mupirocin-Calcium |
KR20060123772A (ko) | 2004-06-01 | 2006-12-04 | 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 | 약물의 비결정형의 제조 방법 |
AU2006215708B2 (en) * | 2005-02-21 | 2011-01-27 | Syngen Biotech Co., Ltd | Purification of mupirocin |
GB2441328A (en) * | 2006-08-30 | 2008-03-05 | Alpharma Aps | A method for obtaining mupirocin calcium |
CN116018342A (zh) * | 2020-08-25 | 2023-04-25 | 杭州中美华东制药有限公司 | 一种莫匹罗星的提取方法 |
-
1971
- 1971-06-12 GB GB2765371A patent/GB1395907A/en not_active Expired
-
1972
- 1972-06-07 DE DE2227739A patent/DE2227739C2/de not_active Expired
- 1972-06-12 CH CH872872A patent/CH584755A5/xx not_active IP Right Cessation
- 1972-06-12 JP JP5850372A patent/JPS548753B1/ja active Pending
-
1976
- 1976-11-12 US US05/741,215 patent/US4289703A/en not_active Expired - Lifetime
-
1978
- 1978-11-04 JP JP13621678A patent/JPS5495796A/ja active Granted
-
1982
- 1982-06-01 BE BE0/208240A patent/BE893376Q/fr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB1395907A (en) | 1975-05-29 |
US4289703A (en) | 1981-09-15 |
DE2227739A1 (de) | 1973-01-04 |
JPS5495796A (en) | 1979-07-28 |
BE893376Q (fr) | 1982-10-01 |
JPS548753B1 (xx) | 1979-04-18 |
JPS5638119B2 (xx) | 1981-09-04 |
DE2227739C2 (de) | 1982-07-29 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased | ||
PL | Patent ceased |